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Researchers have been looking for factors that can 
influence the prognosis of oral cancer, because its outcome 
is highly uncertain. Aim: To evaluate variables that can 
impact the survival rate of patients with squamous-cell 
carcinoma of the oral cavity. Material and Methods: Data 
analysis of 45 patients from January, 2001 to January, 2006. 
Survival rate curves have been estimated using the Kaplan-
Meier method and they have been compared through the 
log-rank test and the Cox regression standard. Study design: 
Retrospective analysis. Results: Total five-year survival rate 
was of 39% fpr these patients. Only the neck metastases 
(p=0.017), postoperative radiotherapy (p=0.056) and 
diseased margin(p=0.004) variables had statistic relevance. 
Survival rate was lower in patients with neck metastases, 
margins involved and those who underwent postoperative 
radiotherapy, in other words, those with the most aggressive 
tumors. After adjustment, radiotherapy did not prove to be 
statistically relevant. It is likely that the survival rate of 39% 
was due to the high number of patients with metastasis 
(52%) and because the samples were mostly of tongue and 
mouth floor diseases (82%), which are the hardest to control. 
Conclusion: Neck metastases and diseased margins of oral 
cavity carcinomas are the prognostic factors that can most 
impact the survival rate.
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INTRODUCTION
According to the World Health Organization 
(WHO), mouth and oropharyngeal cancers are the most 
frequent head and neck malignancies; 390 thousand new 
cases are reported every year.1 In Brazil, mouth and oro-
pharyngeal cancers are the fifth most frequent malignan-
cies among males (9.2% of cases) and the seventh most 
frequent in females (3.6% of cases) not including skin 
cancers.2 In total these malignancies are 6.7% of all cancer 
cases. These malignancies occur most frequently in south 
and southeast Brazil.2,3 Estimates for 2007 had suggested 
that there would be 10.91 new cases or mouth cancer for 
each 100,000 males and 3.58 new cases for each 100,000 
females.4 The incidence rate is increasing and the WHO 
foresees further increase in the next decades.5 Around 95% 
of mouth cancers are squamous cell carcinomas (SCC); 
the remaining 5% are sarcomas, lymphomas and salivary 
gland tumors.
The prognosis of oral cancer remains unfavorable 
with high mortality rates, notwithstanding advances in 
diagnosis and therapy, including radical surgery, novel 
chemotherapy, and hyperfractionated/conformational ra-
diotherapy. Mortality rates have ranged from 2.16 to 2.96 
for each 100,000 males and 0.48 and 0.70 for each 100,000 
females6 between 1979 and 1998 in Brazil; the mortality 
rate has increased at an annual 0.72% rate.7 According 
to Sessions et al., the 5-year survival rate remains low, 
at about 48% (overall survival) and 57% (disease-specific 
survival).8
The biological behavior of oral SCC is uncertain; 
many of these tumors have an aggressive biological beha-
vior at initial stages with early regional metastases and 
death. On the other hand, advanced tumors may metas-
tasize slowly, and these patients may remain disease-free 
for long periods after surgery.
This uncertainty in tumor progression has led rese-
archers to seek factors that might alter the prognosis. Such 
factors may be related to patients (age, sex, race, social and 
economic status, and habits such as smoking and alcohol 
intake), to the tumor (site, stage, tumor thickness, histo-
pathology, and expression of certain molecular markers), 
and to the treatment (type of treatment, adjuvant therapy). 
Investigation of these factors aims to learn more about the 
biological behavior of the tumor, so that specific strategies 
may be applied individually; thus aggressive therapy may 
be given to patients with the worst prognosis.
The presence of neck metastases is the most impor-
tant prognostic factor for oral SCC; if present, there is a 50% 
reduction in survival rates.9,10 TNM staging, the histological 
grade and safety margins are other factors with unknown 
roles. Some studies have suggested that TNM staging (a 
tool used for establishing a prognosis) cannot predict in-
dividual tumor biological behavior. The prognostic value 
of the histological grade is controversial in this tumor;11 
studies have suggested that poorly differentiated carci-
nomas tend to metastasize and to have involved margins 
more often. These tumors are associated with decreased 
survival rates.12 There is still controversy in the literature 
about margin status.
The purpose of this paper was to evaluate variables 
related to patient, tumor and treatment variables affecting 
survival rates in mouth SCC.
MATERIAL AND METHOD
 
Patients
Information about 45 patients with primary mouth 
SCC, between January 2001 and January 2006, from the 
“Head & Neck Surgical Sample Bank” was reviewed. The 
Research Ethics Committee approved this study (protocol 
number 9371/2003). Data was collected about patients 
(age, sex, smoking and alcohol intake), the tumor (site, 
TNM stage, degree of differentiation, vascular, lymphatic 
and perineural spread, inflammation around the tumor), 
treatment (margin status, postoperative radiotherapy), and 
progression. We were unable to separate patients that 
died due to the tumor or due to other causes; thus, only 
overall survival was calculated, rather than the disease-
specific survival.
Patients with primary mouth SCC treated initially 
with curative surgery at our institution, from which bio-
logical material was biopsied during surgery and stored, 
with follow-up and documented histological data kept 
at the database of the Genome Project, were included. 
Patients with lip tumors and patients with no follow-up 
were excluded.
 
Diagnosis and staging
Tumor diagnosis was based on a clinical examina-
tion followed by a biopsy of the lesion and pathology. 
Computed tomography was done to assess tumor spread 
and the presence of cervical nodes. All patients were sta-
ged according to the International Union Against Cancer 
(UICC) 2002 guidelines.
 
Treatment and Follow-up
All patients underwent surgical removal with safety 
margins of the primary lesions with a curative intent. Radi-
cal neck dissection was done for removing neck metastases 
identified clinically or radiologically; elective neck dissec-
tion was done in T2 to T4-staged patients with no neck 
metastases. Patients with T4-staged tumors or in whom 
histopathology revealed involved margins, angiolymphatic 
or perineural spread, or lymph node metastases underwent 
postoperative radiotherapy. Following the treatment pa-
tients returned on the 1st, 3rd, 6th and 12th months in the 
first year and thereafter every 6 months.
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Statistical analysis
Survival curves for each variable were estimated 
using the Kaplan-Meier method; the log-rank test was used 
for comparison purposes. The Cox regression model was 
used for checking the effect of each variable after each 
was adjusted to the same level (Hosmer & Lemeshow, 
1999).13
RESULTS
 
Description of the sample
Table 1 shows the frequency distribution for each 
level of each variable according to the vital status of pa-
tients. The five levels of the subsite variable were grouped 
into three levels: floor of the mouth, tongue, and other 
(gingival, n=5; palate, n=1; and retromolar, n=2) to make 
the survival analysis feasible. The poorly differentiated 
group contained only two patients, and was therefore 
added to the group of moderately differentiated tumor 
group. The mean age was 56.3 years, the standard devia-
tion was 10.3 years; the age percentages were as follows: 
P25=52 years, P50(median)=55 years, and P75=63 years. 
Fifty percent of patients were aged between 55 and 63 
years. Age was dichotomized and limited to 60 years in 
the survival analysis.
Answers on the variables sex and smoking were 
concentrated in only one level, as follows: 40 (88.9%) of 
patients were male and 39 (86,7%) patients were smokers. 
There was thus less assurance in the test results involving 
these two variables.
 
Estimated survival curves
The estimated overall survival curve by the Kaplan-
Meier method and the 5-year survival rate was 39% (Fig. 
1).
The log-rank test, which tests the effect of each 
variable singly on survival, revealed the following signi-
ficant factors: neck metastasis (p=0.017), postoperative 
radiotherapy (p=0.056) and involved margins (p=0.004). 
The other variables had p values equal to or over 0.24. 
Figs. 2, 3 and 4 show the estimated survival probabilities 
and curves for the abovementioned three variables. For 
instance, Fig. 2 shows that the estimated probability of 
surviving more than 9 months was 95% (CI-95%: 68%-99%) 
for metastasis-free patients, and 73% (CI-95%: 52%-86%) 
for patients with metastases. Survival was lower in pa-
tients with neck metastases that underwent postoperative 
radiotherapy and who had involved margins (Figs. 3 and 
4). The results of radiotherapy seem contradictory, as one 
would expect increased survival when using this treatment. 
Eighteen (81.8%) of 22 patients undergoing radiotherapy 
had neck metastases, in other words, patients with more 
aggressive tumors.
Figure 1. Representation of the survival curve of patients with mouth 
cancer, estimated by the Kaplan-Meier method.
Figure 2. Representation of survival curves for the presence and 
absence of neck metastases, estimated by the Kaplan-Meier method 
(p=0.017, according to the log-rank).
Figure 3. Representation of survival curves for postoperative radiothe-
rapy and its absence, estimated by the Kaplan-Meier method (p=0.056, 
according to the log-rank).
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Table 1. Distribution of variable frequencies in 45 operated patients with mouth cancer between 2001 and 2006, according to the vital status.
Variable         
Death    Non death    
Total
n % n %
Sex Male 22 55,0 18 45,0 40
Age Female 2 40,0 3 60,0 5
Smoking ³ 60 years 7 46,7 8 53,3 15
Alcohol use < 60 years 17 56,7 13 43,3 30
Subsite Yes 21 53,9 18 46,1 39
T staging No 3 50,0 3 50,0 6
N staging Yes 18 58,1 13 41,9 31
Postoperative radiotherapy No 6 42,9 8 57,1 14
Differentiation grade Floor 10 55,6 8 44,4 18
Vascular spreadr Gingiva 2 40,0 3 60,0 5
Lymphatic spread Tongue 11 57,9 8 42,1 19
Perineural spread Palate 0 0 1 100,0 1
Peritumor inflammation Retromolar 1 50,0 1 50,0 2
Margins    T1 4 50,0 4 50,0 8
T2 12 54,6 10 46,4 22
T3 5 55,6 4 44,4 9
T4 3 50,0 3 50,0 6
N 17 65,4 9 34,6 26
N- 7 36,8 12 63,2 19
Yes 14 63,6 8 36,4 22
No 10 43,5 13 56,5 23
Well differentiated 11 47,8 12 52,2 23
Moderately diff 11 55,0 9 45,0 20
Poorly differentiated 2 100,0 0 0 2
Presence 4 44,4 5 55,6 9
Absence 20 55,6 16 44,4 36
Presence 5 55,6 4 44,4 9
Absence 19 52,8 17 47,2 36
Presence 4 36,4 7 63,6 11
Absence 20 58,8 14 41,2 34
Intense 1 20,0 4 80,0 5
Moderate 6 66,7 3 33,3 9
Absent 17 54,8 14 45,2 31
Compromised 11 78,6 3 21,4 14
Free 12 40,0 18 60,0 30
Not assessed 1 100,0 0 0 1
Total 24 53,3 21 46,7 45
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Effect adjusted
The variables metastasis, radiotherapy and margins 
were considered jointly in the Cox regression model to veri-
fy the effect of each variable and their relation with other in 
the same level. Radiotherapy was not significant (p=0.816), 
while metastasis (p=0.002) and margins (p<0.001) were 
relevant factors for patient survival times.
DISCUSSION
Mouth SCCs have a poor prognosis and tend to recur 
in the primary site and the neck. The 5-year survival rate 
in our sample was 39%, which is lower than other publi-
shed results. This is probably due to the higher presence 
of patients with metastatic lymph nodes (52.2%) and the 
fact that the sample consisted mostly of tongue and floor 
of mouth cancers (82%), which are recognizably more di-
fficult to control. These values differ from Sessions et al.’s 
series in which only 26% of patients had metastatic lymph 
nodes.8 Furthermore, our sample contained 34.8% of T3/
T4 tumors; this percentage in Sessions et al.’s series was 
26.5%.8 Additionally the biological behavior of mouth SCCs 
is heterogeneous, depending of poorly known host and 
primary tumor factors. Figueiredo et al. have previously 
published data on the first 15 mouth tumors in our present 
series, showing that these patients expressed highly the 
PRAME gene; this finding is related with the presence of 
lymphatic metastases.14
We detected no patient-related factor among tho-
se we studied that had any effect on survival; age, sex, 
smoking and alcohol use had no statistically significant 
effect. There is no consensus in the literature about the 
influence of these factors; according to EIBAND, there 
is no correlation with age, sex or the prognosis,15 while 
smoking and alcohol use are seen as risk rather than 
prognostic factors.
Tumor-related factors (subsite, size, tumor differen-
tiation, peritumor inflammation, and vascular, lymphatic 
and perineural spread) had no statistical significance. Ka-
demani et al. have shown that the tumor site has not effect 
on survival; these authors did suggest that the histological 
grade was a statistically significant prognostic factor.12 The 
histological grade appears not to have affected survival due 
to the limited number of cases of undifferentiated carci-
nomas in our sample (two cases). There is no consensus 
in the literature about whether vascular, lymphatic and 
perineural spread decrease survival.16 The sensitivity of 
the method for detecting spread (immunohistochemistry 
is much more sensitive than hematoxyllin-eosin) and the 
expertise of the pathologist may explain these conflicting 
conclusions.
Neck metastasis was the only tumor-related factor 
that has been shown to decrease survival in this sample 
(p=0.017), confirming most of the corresponding published 
results.9,10 It is relevant to point out that the metastatic rate 
in our sample of mouth cancers was 57.7%.
Treatment-related factors, such as compromised 
surgical margins and supplementary radiotherapy, had an 
impact on survival. Confirmation that margin status has an 
effect on survival is important, as compromised margins 
may be avoided by ample surgical resection. According 
to Mistry et al., however, this is not an easy task; these 
authors found that measurements of free mucosal margins 
- attained in surgery - decreased by up to 23% postope-
ratively, particularly in T1/T2 tumors.19 Spiro et al. found 
an increased local recurrence in patients with involved 
margins, which did not alter overall survival.18
The presence of compromised margins, which was 
statistically significant (p=0.004) in our sample, agrees 
with Sessions et al.’s results in showing that compromised 
margins decreased disease-free survival; these authors also 
found that when patients with compromised margins un-
derwent postoperative radiotherapy, disease-specific survi-
val increased significantly.8 Chao et al. also demonstrated 
that postoperative radiotherapy provided good results in 
patients with compromised margins; this group of patients 
had the same survival and local control that was found 
in patients with free margins. Postoperative radiotherapy 
did not improve survival in our sample.17 Other authors 
also did not find the abovementioned significance (Ka-
demi et al.).12
The log-rank test showed that postoperative ra-
diotherapy (p=0.056) had an opposite effect, namely that 
patients undergoing radiotherapy had a lower survival rate. 
Radiotherapy was not statistically significant (p=0,816), 
however, when considering radiotherapy, neck metastasis 
and compromised margins jointly in the Cox regression 
model; other variables were statistically significant. This 
may be a result of indication of treatment criteria whereby 
only more aggressive tumors were treated with radiothera-
Figure 4. Representation of survival curves for free and compromised 
margins, estimated by the Kaplan-Meier method (p=0.004, according 
to the log-rank).
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py postoperatively. Radiotherapy should be indicated care-
fully - as well as taking into account tumor aggressiveness 
- as according to Brandwein-Gensler et al., radiotherapy 
is only useful when applied in cases with a high risk of 
recurrence (truly compromised margins).21
While Ord et al.’s study involved only one surgeon 
- to decrease added effects20 - many surgeons participated 
in our study, as our institution has a residency program.
Molecular assessment may provide additional infor-
mation about tumors; thus the Gencapo study group - in 
counting tumors in many institutions - may in the near 
future provide relevant data for improving individual 
treatment.
CONCLUSION
We may conclude that neck metastases from mou-
th SCCs (a tumor-related prognostic factor) and surgical 
margin status (related to therapy) affected the survival of 
patients.
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